Pediatric cancer patients in clinical trials of sepsis: Factors that predispose to sepsis and stratify outcome

Pediatric Critical Care Medicine

Volumn 6, Issue 3 SUPPL., 2005, Pages

  Tamburro, Robert ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; Hematopoietic stem cell transplant; Mortality; Pediatrics; Sepsis

Indexed keywords

CEFEPIME; FLUDARABINE; IMMUNOSUPPRESSIVE AGENT; MEROPENEM;

CANCER PATIENT; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; COMORBIDITY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEBRILE NEUTROPENIA; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFORMED CONSENT; INTENSIVE CARE; LEUKEMIA; MEDICAL LITERATURE; MEDLINE; MORTALITY; NONHODGKIN LYMPHOMA; OUTCOMES RESEARCH; PATIENT ATTITUDE; PATIENT SELECTION; PEER REVIEW; PRIORITY JOURNAL; PROBABILITY; RANDOMIZATION; REVIEW; SEPSIS; SURVIVAL RATE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; NEOPLASMS; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SEPSIS; TREATMENT OUTCOME;

EID: 19444367955     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000161288.00396.49     Document Type: Review

References (35)

1. Watson RS, Carcillo JA, Linde-Zwirble WT, et al: The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003; 167:695-701
2. Kutko MC, Calarco MP, Flaherty MB, et al: Mortality rates in pediatric septic shock with and without multiple organ system failure. Pediatr Crit Care Med 2003; 4:333-337
3. Fiser RT, West NK, Bush AJ, et al: Outcome of severe sepsis in pediatric oncology patients. Pediatr Crit Care Med In Press
4. Viscoli C, Castagnola E, Giacchino, M, et al: Bloodstream infections in children with cancer: A multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive Therapy Group-Infectious Diseases Section. Eur J Cancer 1999; 35:770-774
5. Pizzo PA, Poplack DG (Eds): Principles and Practice of Pediatric Oncology. Fourth Edition. Philadelphia, Lippincott Williams and Wilkins, 2002
6. Hann I, Viscoli C, Paesmans M, et al: A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol 1997; 99:580-588
7. Kutluk T, Kurne O, Akyuz C, et al: Cefepime vs. Meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours. Pediatr Blood Cancer 2004; 42:284-286
8. Haupt R, Romanengo M, Fears T, et al: Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: A 12-year experience at a single Italian institution. Eur J Cancer 2001; 37: 2413-2419
9. Ammann RA, Hirt A, Luthy AR, et al: Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Pediatr Infect Dis J 2004; 23:61-67
10. Tam CS, Wolf MM, Januszewicz EH, et al: A new model for predicting infectious complications during fludarabine-based combination chemotherapy among patients with indolent lymphoid malignancies. Cancer 2004; 101:2042-2049
11. Gonzalez-Barca E, Fernandez-Sevilla A, Carratala J, et al: Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia. Eur J Clin Microbiol Infect Dis 1999; 18:539-544
12. West DC, Marcin JP, Mawis R, et al: Children with cancer, fever, and treatment-induced neutropenia: Risk factors associated with illness requiring the administration of critical care therapies. Pediatr Emerg Care 2004; 20:79-84
13. Rackoff WR, Gonin R, Robinson C, et al: Predicting the risk of bacteremia in children with fever and neutropenia. J Clin Oncol 1996; 14:919-924
14. Bodey GP, Buckley M, Sathe YS, et al: Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328-340
15. Darmon M, Azoulay E, Alberti C, et al: Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients. Intensive Care Med 2002; 28: 1775-1780
16. Staudinger T, Stoiser B, Mullner M, et al: Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 2000; 28:1322-1328
17. Wisplinghoff H, Seifert H, Wenzel RP, et al: Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003; 36:1103-1110
18. Regazzoni CJ, Khoury M, Irrazabal C, et al: Neutropenia and the development of the systemic inflammatory response syndrome. Intensive Care Med 2003; 29:135-138
19. Baorto EP, Aquino VM, Mullen CA, et al: Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer 2001; 92:909-913
20. McMillan JA, DeAngelis CD, Feigin RD, et al (Eds): Oski's Pediatrics: Principles and Practice. Third Edition. Philadelphia, Lippincott Williams and Wilkins, 1999
21. Larche J, Azoulay E, Fieux F, et al: Improved survival of critically ill cancer patients with septic shock. Intensive Care Med 2003; 29: 1688-1695
22. Sauer M, Tiede K, Fuchs D, et al: Procalcitonin, C-reactive protein, and endotoxin after bone marrow transplantation: Identification of children at high risk of morbidity and mortality from sepsis. Bone Marrow Transplant 2003; 31:1137-1142
23. Pastores SM, Papadopoulos E, van den Brink M, et al: Septic shock and multiple organ failure after hematopoietic stem cell transplantation: Treatment with recombinant human activated protein C. Bone Marrow Transplant 2002; 30:131-134
24. Lum LG: The kinetics of immune reconstitution after human marrow transplantation. Blood 1987; 69:369-380
25. DiCarlo JV, Alexander SR, Agarwal R, et al: Continuous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy. J Pediatr Hematol Oncol 2003; 25:801-805
26. Afessa B, Litzow MR, Tefferi A: Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28:425-434
27. Levine JE, Harris RE, Loberiza FR Jr, et al: A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma: Lymphoma Study Writing Committee, International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry. Blood 2003; 101:2476-2482
28. Weisdorf D, Bishop M, Dharan B, et al: Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: Comparative toxicity and outcomes. Biol Blood Marrow Transplant 2002; 8:213-220
29. Engelhard D, Cordonnier C, Shaw PJ, et al: Early and late invasive pneumococcal infection following stem cell transplantation: A European Bone Marrow Transplantation survey. Infectious Disease Working Party of the European Bone Marrow Transplantation (IDWP-EBMT). Br J Haematol 2002; 117: 444-450
30. Diaz MA, Vicent MG, Prudencio M, et al: Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation. Haematologica 2002; 87:292-298
31. Tamburro RF, West NK, Piercy J, et al: Use of the nursing acuity score in children admitted to a pediatric oncology intensive care unit. Pediatr Crit Care Med 2004; 5:35-39
32. Schneider DT, Lemburg P, Sprock I, et al: Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children. Bone Marrow Transplant 2000; 25: 1079-1086
33. Schneider DT, Cho J, Laws HJ, et al: Serial evaluation of the oncological pediatric risk of mortality (O-PRISM) score following allogeneic bone marrow transplantation in children. Bone Marrow Transplant 2002; 29: 383-389
34. Tomaske M, Bosk A, Eyrich M, et al: Risks of mortality in children admitted to the paediatric intensive care unit after haematopoietic stem cell transplantation. Br J Haematol 2003; 121:886-891
35. Cheuk DK, Ha SY, Lee SL, et al: Prognostic factors in children requiring admission to an intensive care unit after hematopoietic stem cell transplant. Hematol Oncol 2004; 22:1-9